Abstract:Abstract Background Inflammatory bowel disease (IBD) is a chronic intestinal immune-dysfunctional disease, while the presence of persistent triggering factors leading to relapsing and remitting inflammation in IBD remains undetermined. The oral cavity is one of the most frequently affected extraintestinal organ in IBD, and literature highlights the oral cavity's influence on gastrointestinal conditions. The understanding of alternative mechanisms in the long-distance interaction between the oral cavity and gut is limited. Exosomes exist in various bodily fluids and facilitate intercellular communication. Thus, we aimed to further explore the role of salivary exosomes in aggravating colitis via bridging oral cavity and gut. Methods Salivary exosomes were obtained from active IBD patients, remission IBD patients, and healthy donors using ultracentrifugation. In vivo, we established a dextran sulfate sodium (DSS)-induced colitis model to investigate the possible role and mechanisms of salivary exosomes. In vitro, THP-1 cells and Caco-2 cells were stimulated with salivary exosomes respectively and the expression of related inflammatory factors was detected. Moreover, our investigated the immune regulatory mechanism of salivary exosomes by analyzing their microRNA profiles. Results DIL-labeled salivary exosomes accumulated in mouse colon at 6 hours post-gavage, indicating their ability to reach and accumulate in the colon through the "oral-gut axis" (Figure 1A). Salivary exosomes of active IBD patients (active IBD-Sexos) exacerbated colitis in DSS mouse, while salivary exosomes derived from remission IBD patients or healthy donors not (Figure1B). The potential mechanisms may include remodeling of macrophage phenotypes by activating the NF-κB signaling pathway (Figure1D-F), impairment of intestinal mucosal barrier function (Figure1C), and modulation of the intestinal microbiota. Co-culture of THP-1 cells and Caco-2 cells with active IBD-Sexos were shown to raise inflammation in macrophages, which lead to increased release of inflammatory factors and promoted macrophage M1 polarization(Figure1G-K). We found 35 differentially expressed microRNAs in active IBD-Sexos compared to exosomes from both remission IBD patients and healthy donors (Figure1L). Specifically, miR-223 regulates the inflammatory response of IBD. MiR-119b-5p and miR-203-5p impact the NF-κB signaling pathway.These microRNAs promote inflammation, suggesting a possible role of salivary exosome delivery in IBD pathogenesis. Conclusion In conclusion, our study provides evidence that salivary exosomes play a significant role in the communication between the oral cavity and gut, beyond microorganisms or immune cells, with the potential to exacerbate intestinal inflammation in IBD (Figure1M).

Colorectal cancer and inflammatory bowel diseases share common salivary proteomic pathways

Salivary Exosomal PSMA7: a Promising Biomarker of Inflammatory Bowel Disease

Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation

Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases

Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome

Article Salivary Exosomes Exacerbate Colitis by Bridging the Oral Cavity and Intestine

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer

Key biomarkers within the colorectal cancer related inflammatory microenvironment

Digital spatial profiling identifies molecular changes involved in development of colitis-associated colorectal cancer

The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease

Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer

P100 Salivary exosomes aggravate colitis via oral-gut axis

The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis

Dysbiosis and Ecotypes of the Salivary Microbiome Associated with Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.

Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications

Microbial Dysbiosis in Colorectal Cancer (CRC) Patients

Incident Colorectal Cancer in Inflammatory Bowel Disease

16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer

P106 Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach

High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease